For research use only. Not for therapeutic Use.
2,3-Diphosphoglyceric acid (2,3-DPG) pentasodium is an intermediate of the glycolytic pathway. 2,3-Diphosphoglyceric acid pentasodium stabilizes the deoxygenated form of hemoglobin by allosteric binding and facilitates oxygen release at tissue sites. 2,3-Diphosphoglyceric acid pentasodium binds to hemoglobin and decrease its affinity for oxygen[1][2].
Catalog Number | R054792 |
CAS Number | 1287756-01-7 |
Synonyms | pentasodium;2,3-diphosphonatooxypropanoate |
Molecular Formula | C3H3Na5O10P2 |
Purity | ≥95% |
InChI | InChI=1S/C3H8O10P2.5Na/c4-3(5)2(13-15(9,10)11)1-12-14(6,7)8;;;;;/h2H,1H2,(H,4,5)(H2,6,7,8)(H2,9,10,11);;;;;/q;5*+1/p-5 |
InChIKey | KPRMRMXBVAUXKZ-UHFFFAOYSA-I |
SMILES | C(C(C(=O)[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+].[Na+] |
Reference | [1]. Shakil H. Merchant MD, et al. 24 – Molecular Diagnosis in Hematopathology. Hematopathology (Second Edition).2012, 679-726. [2]. Płoszczyca K, et al. Red Blood Cell 2,3-Diphosphoglycerate Decreases in Response to a 30 km Time Trial Under Hypoxia in Cyclists. Front Physiol. 2021 Jun 15;12:670977. |